These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 23815256)

  • 1. Cardiac effects of echinocandin preparations - three case reports.
    Lichtenstern C; Wolff M; Arens C; Klie F; Majeed RW; Henrich M; Uhle F; Weiterer S; Röhrig R; Weigand MA
    J Clin Pharm Ther; 2013 Oct; 38(5):429-31. PubMed ID: 23815256
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of echinocandin administration on hemodynamic parameters in medical intensive care unit patients: a single center prospective study.
    Lahmer T; Schnappauf C; Messer M; Rasch S; Fekecs L; Beitz A; Eser S; Schmid RM; Huber W
    Infection; 2015 Dec; 43(6):723-7. PubMed ID: 26259643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A severe case of haemodynamic instability during anidulafungin administration.
    Fink M; Zerlauth U; Kaulfersch C; Rab A; Alberer D; Preiss P; Sternad-Klobschauer K; Habernig E; Wandschneider W; Grimm G
    J Clin Pharm Ther; 2013 Jun; 38(3):241-2. PubMed ID: 23550735
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiac effects of echinocandins after central venous administration in adult rats.
    Koch C; Uhle F; Wolff M; Arens C; Schulte A; Li L; Niemann B; Henrich M; Rohrbach S; Weigand MA; Lichtenstern C
    Antimicrob Agents Chemother; 2015 Mar; 59(3):1612-9. PubMed ID: 25547351
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anidulafungin in the treatment of patients with invasive candidiasis.
    Kett DH; Cubillos GF
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 2():S99-S102. PubMed ID: 19013348
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Echinocandins in invasive candidiasis].
    Glöckner A; Cornely OA
    Med Klin (Munich); 2008 Jun; 103(6):397-405. PubMed ID: 18548209
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Echinocandin use in the neonatal intensive care unit.
    Caudle KE; Inger AG; Butler DR; Rogers PD
    Ann Pharmacother; 2012 Jan; 46(1):108-16. PubMed ID: 22190252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cardiac toxicity of the echinocandins: chance or cause and effect association?
    Stover KR; King ST; Cleary JD
    J Clin Pharm Ther; 2014 Feb; 39(1):1-3. PubMed ID: 24383937
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Impact of echinocandin on prognosis of proven invasive candidiasis in ICU: A post-hoc causal inference model using the AmarCAND2 study.
    Bailly S; Leroy O; Azoulay E; Montravers P; Constantin JM; Dupont H; Guillemot D; Lortholary O; Mira JP; Perrigault PF; Gangneux JP; Timsit JF;
    J Infect; 2017 Apr; 74(4):408-417. PubMed ID: 28104387
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Echinocandins: the newest class of antifungals.
    Sucher AJ; Chahine EB; Balcer HE
    Ann Pharmacother; 2009 Oct; 43(10):1647-57. PubMed ID: 19724014
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy and safety of anidulafungin in elderly, critically ill patients with invasive Candida infections: a post hoc analysis.
    Dimopoulos G; Paiva JA; Meersseman W; Pachl J; Grigoras I; Sganga G; Montravers P; Auzinger G; Sá MB; Miller PJ; Marček T; Kantecki M; Ruhnke M
    Int J Antimicrob Agents; 2012 Dec; 40(6):521-6. PubMed ID: 22998997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Echinocandin-induced eosinophilia: a case report.
    Chua NG; Zhou YP; Lingegowda PB; Kwa AL; Lee W
    Scand J Infect Dis; 2014 Nov; 46(11):809-12. PubMed ID: 25119439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hemodynamic changes in surgical intensive care unit patients undergoing echinocandin treatment.
    Koch C; Schneck E; Arens C; Markmann M; Sander M; Henrich M; Weigand MA; Lichtenstern C
    Int J Clin Pharm; 2020 Feb; 42(1):72-79. PubMed ID: 31748967
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Anidulafungin: a new echinocandin with a novel profile.
    Vazquez JA
    Clin Ther; 2005 Jun; 27(6):657-73. PubMed ID: 16117974
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of invasive candidiasis with echinocandins.
    Glöckner A; Steinbach A; Vehreschild JJ; Cornely OA
    Mycoses; 2009 Nov; 52(6):476-86. PubMed ID: 19076282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Flash pulmonary oedema during anidulafungin administration.
    Hindahl CB; Wilson JW
    J Clin Pharm Ther; 2012 Aug; 37(4):491-3. PubMed ID: 22017245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The echinocandins.
    Cappelletty D; Eiselstein-McKitrick K
    Pharmacotherapy; 2007 Mar; 27(3):369-88. PubMed ID: 17316149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early clinical experience with anidulafungin at a large tertiary care medical center.
    Brielmaier BD; Casabar E; Kurtzeborn CM; McKinnon PS; Ritchie DJ
    Pharmacotherapy; 2008 Jan; 28(1):64-73. PubMed ID: 18154476
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anidulafungin: a novel echinocandin for candida infections.
    de la Torre P; Meyer DK; Reboli AC
    Future Microbiol; 2008 Dec; 3(6):593-601. PubMed ID: 19072176
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anidulafungin: is it a promising option in the treatment of pediatric invasive fungal infections?
    Tapısız A
    Expert Rev Anti Infect Ther; 2011 Mar; 9(3):339-46. PubMed ID: 21417873
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.